日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Spatiotemporally engineered microneedle for microenvironment remodeling propels mucosal regeneration after tracheal mucosal injury.

时空工程化的微针可重塑微环境，促进气管黏膜损伤后的黏膜再生。

期刊:Bioactive Materials
影响因子:20.3
doi:10.1016/j.bioactmat.2026.01.026
Wang Pengli, Ci Zheng, Zhao Enmin, Hu Chuang, Chen Baiyi, Gao Erji, Bo Qitao, Bian Chengyu, Li Yaqiang, Song Xiao, Zhou Guangdong, Xu Tingting, Duan Liang
发表日期：2026
文献求助 收藏

From radiologic morphology to component proportion: a multicenter study on the progression and prognosis of lung adenocarcinoma with cystic airspaces

从放射形态学到成分比例：一项关于伴有囊性气腔的肺腺癌进展和预后的多中心研究

期刊:Cancer Imaging
影响因子:3.5
doi:10.1186/s40644-026-01009-9
Fu, Chenghao; Bian, Chengyu; Du, Haonan; Wang, Yuheng; Zhang, Jia; Li, Xiang; Cao, Lei; Zhu, Jian; Wang, Jun
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Multi-omics comprehensive analysis identified KIF22 and KRAS as highly synthetic lethal pairs for triple-negative breast cancer.

多组学综合分析发现 KIF22 和 KRAS 是三阴性乳腺癌中高度合成致死的组合。

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2026.1748954
Miao Shichen, Wang Xiao, Gu Qiming, Bian Chengyu, Fan Rui, Ni Qichao, Wang Yi, Zhuang Zhigang
乳腺癌
肿瘤
RAS
发表日期：2026
文献求助 收藏

Case Report: Durable complete response to antigen-specific cytotoxic T lymphocyte therapy in advanced EGFR-TKI resistant lung adenocarcinoma: a case of adoptive cellular immunotherapy overcoming acquired targeted resistance

病例报告：抗原特异性细胞毒性T淋巴细胞疗法在晚期EGFR-TKI耐药肺腺癌中实现持久完全缓解：一例过继性细胞免疫疗法克服获得性靶向耐药的病例

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1637165
Fu, Chenghao; Bian, Chengyu; Zhu, Weiyou; Du, Haonan; Han, Linrui; Zhu, Jian; Wang, Jun; Cao, Lei
肿瘤
肿瘤免疫
EGF
EGFR
细胞生物学
毒理研究
免疫/内分泌
发表日期：2025
文献求助 收藏

The P4HB/LGALS3BP/NF-kB axis promotes the progression of MIA to IAC in lung adenocarcinoma.

P4HB/LGALS3BP/NF-kB 轴促进肺腺癌中 MIA 向 IAC 的进展

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-12661-9
Mu Guang, Zhang Wenhao, Gu Yan, Wang Hongchang, Huang Jingjing, Bian Chengyu, Wei Ke, Xia Yang, Wang Jun
肿瘤
肺癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Rivaroxaban versus low-molecular-weight heparins for short- and long-term prognosis in patients with deep vein thrombosis after spontaneous intracranial hemorrhage

利伐沙班与低分子肝素治疗自发性颅内出血后深静脉血栓形成患者的短期和长期预后比较

期刊:Journal of Comparative Effectiveness Research
影响因子:2.5
doi:10.57264/cer-2025-0030
Li, Jingfan; Song, Qi; Zhang, Gaopan; Tong, Guannan; Bian, Chengyu; Zhang, Huimei; Zheng, Hulin; Wang, Yafei
深静脉血栓
心血管
发表日期：2025
文献求助 收藏

Inter-multisegmental veins (IMSVs): a new positional indication for pulmonary segmentectomy

多节段间静脉（IMSVs）：肺段切除术的一种新的定位适应症

期刊:Journal of Thoracic Disease
影响因子:1.9
doi:10.21037/jtd-24-1799
Bian, Chengyu; Fu, Chenghao; Wang, Yuheng; Huang, Jingjing; Yuan, Mei; Chen, Liang; Wang, Qianyun; Wang, Jun
多发性硬化症
发表日期：2025
文献求助 收藏

Three-dimensional reconstruction for determining positional indications of pulmonary segmentectomy/subsegmentectomy for ground glass opacity-dominant clinical T1a-bN0 non-small cell lung cancer

三维重建用于确定以磨玻璃影为主的临床T1a-bN0期非小细胞肺癌肺段切除术/亚段切除术的定位指征

期刊:Translational Lung Cancer Research
影响因子:3.5
doi:10.21037/tlcr-24-595
Bian, Chengyu; Fu, Chenghao; Xue, Wentao; Gu, Yan; Wang, Hongchang; Zhang, Wenhao; Mu, Guang; Yuan, Mei; Chen, Liang; Huang, Jingjing; Wang, Qianyun; Wang, Jun
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Anatomic and clinical implications of venous drainage variations in superior segment resections for clinical T1N0 non-small cell lung cancer

静脉引流变异在临床T1N0期非小细胞肺癌上段切除术中的解剖学和临床意义

期刊:Translational Lung Cancer Research
影响因子:3.5
doi:10.21037/tlcr-24-807
Bian, Chengyu; Fu, Chenghao; Xue, Wentao; Gu, Yan; Wang, Hongchang; Zhang, Wenhao; Mu, Guang; Yuan, Mei; Chen, Liang; Wang, Qianyun; Wang, Jun
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Lymph node metastasis and its risk factors in T1 lung adenocarcinoma

T1期肺腺癌淋巴结转移及其危险因素

期刊:Thoracic Cancer
影响因子:2.3
doi:10.1111/1759-7714.15088
Zhang, Wenhao; Mu, Guang; Huang, Jingjing; Bian, Chengyu; Wang, Hongchang; Gu, Yan; Xia, Yang; Chen, Liang; Yuan, Mei; Wang, Jun
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏